IRIS UniCatt

Criscuolo, Marianna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.499
EU - Europa 3.465
AS - Asia 3.152
SA - Sud America 590
AF - Africa 95
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 7
Totale 11.822
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.378
SG - Singapore 1.405
DE - Germania 1.111
CN - Cina 800
SE - Svezia 519
BR - Brasile 475
NL - Olanda 375
IT - Italia 325
VN - Vietnam 271
FR - Francia 262
UA - Ucraina 201
IN - India 149
PL - Polonia 141
IE - Irlanda 129
GB - Regno Unito 116
ID - Indonesia 92
RU - Federazione Russa 73
FI - Finlandia 71
JP - Giappone 59
BD - Bangladesh 56
CA - Canada 54
HK - Hong Kong 53
TR - Turchia 48
MX - Messico 40
AR - Argentina 38
IQ - Iraq 35
ZA - Sudafrica 31
ES - Italia 28
PK - Pakistan 26
SA - Arabia Saudita 23
KR - Corea 20
NO - Norvegia 19
BE - Belgio 18
AT - Austria 16
CO - Colombia 15
EC - Ecuador 14
AU - Australia 13
CL - Cile 13
CI - Costa d'Avorio 12
JO - Giordania 12
UZ - Uzbekistan 12
VE - Venezuela 11
AE - Emirati Arabi Uniti 10
MA - Marocco 10
PH - Filippine 10
CZ - Repubblica Ceca 9
IR - Iran 9
LT - Lituania 9
EG - Egitto 8
PY - Paraguay 8
BO - Bolivia 7
GR - Grecia 7
KE - Kenya 7
MY - Malesia 7
NP - Nepal 7
PS - Palestinian Territory 7
TH - Thailandia 7
DZ - Algeria 6
IL - Israele 6
JM - Giamaica 6
PE - Perù 6
AZ - Azerbaigian 5
CH - Svizzera 5
KZ - Kazakistan 5
RO - Romania 5
DO - Repubblica Dominicana 4
ET - Etiopia 4
HN - Honduras 4
HU - Ungheria 4
TN - Tunisia 4
BB - Barbados 3
BG - Bulgaria 3
GE - Georgia 3
HR - Croazia 3
KG - Kirghizistan 3
LV - Lettonia 3
MD - Moldavia 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
AL - Albania 2
AM - Armenia 2
AO - Angola 2
BW - Botswana 2
CR - Costa Rica 2
EU - Europa 2
GH - Ghana 2
GT - Guatemala 2
LA - Repubblica Popolare Democratica del Laos 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
DK - Danimarca 1
FJ - Figi 1
GF - Guiana Francese 1
IS - Islanda 1
KH - Cambogia 1
Totale 11.805
Salva come PNG Salva come JPEG
Città #
Singapore 805
Chandler 559
San Jose 457
Ashburn 368
Amsterdam 350
Frankfurt am Main 159
Jacksonville 142
Los Angeles 136
Beijing 133
Chicago 133
Warsaw 127
Dublin 123
New York 118
San Mateo 113
Ann Arbor 109
Dearborn 97
Houston 97
Ho Chi Minh City 95
Woodbridge 95
Nanjing 94
Munich 90
Jakarta 83
Wilmington 83
Lauterbourg 82
Hefei 69
Hanoi 66
Milan 64
St Louis 62
Buffalo 57
Fairfield 57
Boston 55
São Paulo 53
Hong Kong 50
Tokyo 47
Hyderabad 46
Moscow 46
Rome 46
Bremen 44
The Dalles 44
Dallas 43
Cattolica 41
Nürnberg 40
Seattle 39
Nanchang 37
Redwood City 37
Lawrence 34
Princeton 34
Santa Clara 34
Marseille 27
Hangzhou 26
Salt Lake City 26
Shanghai 26
London 25
Montreal 25
Orem 25
Leawood 20
Shenyang 20
Cambridge 19
Council Bluffs 19
Mountain View 19
Brussels 18
Da Nang 18
Kunming 18
Tianjin 18
Izmir 17
Redmond 17
Seoul 17
Brooklyn 16
Chatsworth 16
Guangzhou 16
Paris 16
Pune 16
Augusta 15
Kent 15
Poplar 15
Auburn Hills 14
Denver 14
Johannesburg 14
Baghdad 13
Dhaka 13
Elk Grove Village 13
Falls Church 13
Jiaxing 13
Mexico City 13
Nuremberg 13
Tampa 13
Zhengzhou 13
Abidjan 12
Amman 12
Atlanta 12
Belo Horizonte 12
Chennai 12
Hebei 12
Lappeenranta 12
Boardman 11
Changsha 11
Norwalk 11
Phoenix 11
Rio de Janeiro 11
Tashkent 11
Totale 6.627
Salva come PNG Salva come JPEG
Nome #
Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study 586
5-azacytidine in chronic myelomonocytic leukemia: case report and review of literature 430
Fanconi anemia gene variants in therapy-related myeloid neoplasms 322
PTEN/PI3K/AKT PATHWAY DYSREGULATION IN MYELODYSPLASTIC GRANULOCYTES 241
Revised International Prognostic Scoring System (IPSS) predicts survival and leukemic evolution of myelodysplastic syndromes significantly better than IPSS and WHO Prognostic Scoring System: validation by the Gruppo Romano Mielodisplasie Italian Regional Database 235
in Higher-Risk Myelodysplastic Syndromes and Low Blast Count Acute Myeloid Leukemia: Results of the BMT-AZA Prospective Study 201
Why methylation is not a marker predictive of response to hypomethylating agents 195
Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia. 192
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 191
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms 188
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the italian network on secondary leukemias. 188
SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms. 185
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma 182
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 180
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 180
Epigenetic changes in therapy-related MDS/AML 179
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas. 176
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 175
Clonal evolution in therapy-related neoplasms 173
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 171
Similarities and differences between therapy-related and elderly acute myeloid leukemia 170
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes 168
Changes in the incidence of candidemia and related mortality in patients with hematologic malignancies in the last ten years. A SEIFEM 2015-B report 166
Primary plasma cell leukemia followed by testicular plasmacytoma 164
Extramedullary Involvement in Acute Myeloid Leukemia. A Single Center Ten Years' Experience 156
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas 152
Tumor lysis syndrome: review of pathogenesis, risk factors and management of a medical emergency 152
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma. 151
The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromes 150
Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine 148
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 147
In vitro Effect of Eltrombopag Alone and in Combination With Azacitidine on Megakaryopoiesis in Patients With Myelodysplastic Syndrome 143
Candidaemia in haematological malignancy patients from a SEIFEM study: Epidemiological patterns according to antifungal prophylaxis 143
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 139
Outcome of therapy-related myeloid neoplasms treated with azacitidine 137
SEIFEM 2017: from real life to an agreement on the use of granulocyte transfusions and colony-stimulating factors for prophylaxis and treatment of infectious complications in patients with hematologic malignant disorders 135
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 133
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS 133
Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey 132
Recombinant human erythropoietin in very elderly patients with myelodysplastic syndromes: results from a retrospective study 131
Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations 128
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 127
Transcription factors implicated in late megakaryopoiesis as markers of outcome after azacitidine and allogeneic stem cell transplantation in myelodysplastic syndrome 127
A population-based study on myelodysplastic syndromes in the Lazio Region (Italy), medical miscoding and 11-year mortality follow-up: The Gruppo Romano-Laziale Mielodisplasie experience of retrospective multicentric registry 125
Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a “Gruppo Romano Mielodisplasie (GROM)” multicenter study 120
Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases: A SEIFEM group position paper 120
Azacitidine in a patient with myelodysplastic syndrome: Impact of switching from a 5-day to the approved 7-day dosing schedule 119
Therapy-related myeloid neoplasms: Clinical perspectives 118
Disseminated geosmithia argillacea infection in a patient with ph-positive acute lymphoblastic leukemia. Case report and literature review 117
Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry 117
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022 115
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry 109
Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes. 108
Systemic mastocytosis revisited with an emphasis on skeletal manifestations 106
High rate of remissions in chronic myelomonocytic leukemia treated with 5-azacytidine: results of an Italian retrospective study 105
Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes 104
Invasive aspergillosis in acute myeloid leukemia: Are we making progress in reducing mortality? 104
SEIFEM 2017: from real life to an agreement on the use of granulocyte transfusions and colony-stimulating factors for prophylaxis and treatment of infectious complications in patients with hematologic malignant disorders 104
Risk of infectious complications in patients with chronic lymphocytic leukemia in the era of BCR inhibitors: a retrospective single institution experience 102
Rapid response of nodular CD30-positive mycosis fungoides to brentuximab vedotin 101
Aggressive Light Chain Myeloma Originating a Double Peak on Serum Electrophoresis: What's Underneath? 101
Allogeneic Transplant for Mycosis Fungoides in Patient with Wiskott-Aldrich Syndrome 98
Impact of invasive aspergillosis occurring during first induction therapy on outcome of acute myeloid leukaemia (SEIFEM-12B study) 97
Second Neoplasms in Italian Patients with Hairy Cell Leukemia after Treatment with Cladribine: A Multicenter Investigation and Literature Review 96
High Incidence of Invasive Fungal Diseases in Patients with FLT3-Mutated AML Treated with Midostaurin: Results of a Multicenter Observational SEIFEM Study 95
Clinical features and prognostic factors of Magnusiomyces (Saprochaete) infections in haematology. A multicentre study of SEIFEM/Fungiscope 95
A bronchoalveolar lavage-driven antimicrobial treatment improves survival in hematologic malignancy patients with detected lung infiltrates: A prospective multicenter study of the SEIFEM group 95
Risk of infectious complications in patients with chronic lymphocytic leukemia in the era of BCR inhibitors: a retrospective single institution experience 95
Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey 95
Invasive aspergillosis in acute myeloid leukemia: Are we making progress in reducing mortality? 94
The validity of the fifth and the 10th Body Mass Index percentile as weight cut-offs for anorexia nervosa in adolescence: No evidence from quantitative and network investigation of psychopathology 93
Fungaemia in haematological malignancies: SEIFEM-2015 survey 92
The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis 90
Isavuconazole in Hematological Patients: Results of a Real-Life Multicentre Observational Seifem Study 87
A review of prophylactic regimens to prevent invasive fungal infections in hematology patients undergoing chemotherapy or stem cell transplantation 85
SARS-CoV-2 Infection In Patients With Mastocytosis: An EPICOVIDEHA Report 84
Deferasirox chelation therapy in patients with transfusion-dependent MDS: a 'real-world' report from two regional Italian registries: Gruppo Romano Mielodisplasie and Registro Basilicata 82
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 80
SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted 79
In vitro effect of eltrombopag alone and in combination with azacitidine on megakaryopoiesis in patients with myelodysplastic syndrome 78
Revision of antifungal strategies definitions for invasive fungal infections (proven/probable/possible) in 461 patients with haematological malignancies (REDEFI-SEIFEM) 74
Unveiling the Hidden Burden: From EPICOVIDEHA to EPIFLUEHA, Exploring the Epidemiology of Respiratory Viral Infections in Hematological Patients 69
Mastocytosis: One Word for Different Diseases 69
Management of latent tuberculosis infection (LTBI) in adult patients with newly diagnosed acute leukemia: results of a survey among Italian centers belonging to SEIFEM (Sorveglianza Epidemiologica Infezioni nelle Emopatie) group 65
Antiviral prophylaxis to prevent herpes simplex virus (HSV) and varicella zoster virus (VZV) reactivation in adult patients with newly diagnosed acute leukemia: results of a survey submitted to Italian centers belonging to SEIFEM (Sorveglianza Epidemiologica Infezioni nelle Emopatie) group 58
Totale 11.942
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.638
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.638
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021142 0 0 0 0 0 0 0 0 0 0 124 18
2021/2022693 64 40 8 29 51 35 13 122 37 72 96 126
2022/20231.452 188 207 123 267 77 181 50 110 157 20 52 20
2023/2024736 37 186 27 27 29 131 60 15 11 26 90 97
2024/20251.856 49 58 129 54 155 24 90 73 228 171 563 262
2025/20264.416 605 92 223 412 680 780 739 196 340 340 9 0
Totale 11.942